Wednesday, 5 February 2020

Virtual Reality in Gaming Market Growth Factors, Applications, Regional Analysis, Key Players and Forecasts by 2026


New York City, 05 Feb 2020:According to a new study published by Polaris Market Research, the global virtual reality (VR) in gaming market is anticipated to reach USD 48.2 billion by 2026. The market for VR in gaming is propelled by factors including, increasing disposable income of people worldwide and continuous improvement in existing gaming technologies including, 3D effects, motion tracking, and interactive graphics for drawing users’ attention. With the increase in spending capacity of people, people are demanding for new sources of entertainment and VR games offers a unique way of entertainment.

The hardware component segment of VR in gaming market held more than 50% of the market share in 2016 and is further expected to lead during the forecast period. The high-cost of hardware components is the major factor for the increasing growth. However, with the increasing demand for these products, the prices are expected to decrease in the near future.


The hardware segment is expected to grow very rapidly, the software segment is anticipated to experience modest growth. Adoption of the virtual reality technology has raised user expectation for enhanced software solutions, hence increasing challenges for developers than before. By Geography, North America region accounted for the largest share for VR gaming in terms of revenue globally in 2017.

The growth of North American market is attributed to accessibility of advanced gaming technology as well as acceptance and adoption of VR gaming products including head mounted displays. Further, Europe accounted for the second dominating region in 2017. However, Asia Pacific is projected to witness the highest growth during the forecast period attributed to constantly increasing online gamers in developing countries such as China and India and a strong gamers base in countries such as Japan, Korea, Singapore, Malaysia and Indonesia.


The players operating in the market are constantly focusing on development of new products to efficiently compete in the highly aggressive market for VR gaming. For instance, Sony launched Project Morpheus VR heads, a head mounted display device that offers high resolution and efficient tracking accuracy. The major players operating in the Virtual Reality in Gaming include Microsoft Corporation, Sony Corporation, Electronic Arts, Nintendo Company Ltd., Linden Labs, Samsung Electronics Co. Ltd., Facebook (Oculus), Google, Inc., HTC Corporation, and Tesla Studios among others. Companies including Microsoft, Sony and Nintendo are the major players operating in the market. 


About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com




on No comments:
Labels: , , ,

Telehealth Market Segmented by Product, Top Manufacturers, Geography Trends & Forecasts to 2026


New York City, 05 Feb 2020:According to a new study published by Polaris Market Research the global telehealth market is anticipated to reach USD 16.7 billion by 2025.

The use of digital technologies to deliver health education, medical care, and public health services by connecting multiple users from distinct locations is known as telehealth. This includes technology-enabled health care services, telemedicine, and services such as monitoring, assessment, communications, education, and prevention. Additionally, it also involves a wide range of videoconferencing, health information, telecommunications, and digital image technologies. The virtual technology and telecommunications are used in telehealth to deliver health care facilities outside of tradition healthcare facilities. 


The telehealth includes virtual health care, where elderly or chronically ill patients are given medical guidance as well as treatment in certain procedures by residing home. The use of telehealth made easy accessibility of medical tools and guidelines for both professionals as well as patients in terms of diagnosis and patient care. 

The global telehealth market is segmented on the basis of component, mode of delivery, end user, and by region. By component, the global telehealth market is further segmented into three major categories, including hardware, software, and services. On the basis of component, the services segment accounted major share in the global telehealth market. The services segment is further segmented into three major types, real-time interactions, remote monitoring, and store-and-forward consultations. The growing awareness and acceptance of remote monitoring solutions, and increasing technological advancement in telecommunication is the key factor responsible for high share of telehealth services in the telehealth industry. The hardware segment by component is further segmented into two types, medical peripheral devices, and monitors. The software segment is further segmented into, standalone software and integrated software’s. The software segment in the telehealth industry is expected to grow at high CAGR during the forecast period. The software is the important tool of telehealth systems. They work as an interface between the database and end users.

By mode of delivery the global telehealth market is further segmented into, web-based, cloud-based, and on premises delivery system. By end user, the global telehealth market is further segmented into providers, payers, patients, and others.


On the basis of region, the telehealth industry is further segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America is estimated to account major share in the global telehealth industry in 2017. The continuous increasing in telehealth funding and government support for telehealth in the region is the one of key factor responsible for growth of the market. The Asia Pacific is expected to register high CAGR during forecast period, owing to growing economy, and rising healthcare expenditure in that region.

The key players operating in global telehealth market includes Medtronic plc, Koninklijke Philips N.V., McKesson Corporation, Tunstall Healthcare Group Ltd, AMD Global Telemedicine, Inc., Medvivo Group Ltd., Vidyo, Inc., Care Innovations, LLC, Cisco Systems, Inc., General Electric Company, and Honeywell Life Care Solutions among others. The increasing investment for telehealth research and development activities across the top players is expected to propel the growth of the global telehealth market.


About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com




on No comments:
Labels: , , ,

Tuesday, 4 February 2020

Ultrasound Devices Market Analytical Overview, Growth Factors, Demand and Trends Forecast to 2026


New York City, 04 Feb 2020:  According to a new research published by Polaris Market Research, the ultrasound devices market is anticipated to reach over USD 12,556 million by 2026. In terms of revenue, the diagnostic devices segment dominated the global market. Geographically, North America is expected to be the leading contributor to the global market revenue in 2017.

The rapidly increasing geriatric population with several chronic diseases and the lower cost and relative safety of ultrasound devices are together boosting the market growth. Increasing awareness among patients regarding early diagnosis coupled with government initiatives aimed at spreading awareness among the masses regarding breast cancer, regular check-up during pregnancy and other health related issue are boosting the market growth.

Get Sample Copy: https://www.polarismarketresearch.com/industry-analysis/ultrasound-devices-market/request-for-sample

Several technological advancements such as enhancing image quality and increasing portability has made ultrasound devices accessible to a larger user base. Also, several private and public institutions are investing in research and development in the field of ultrasound imaging. Improving healthcare facilities and increasing disposable incomes in developing countries is further fuelling the market growth. However, stringent FDA regulations and lack of trained professionals have limited the market penetration of this technology. Furthermore, several developing countries prohibit the use of ultrasound for gender determination which in turn impedes that industry growth. Identification of newer fields of application and untapped markets in developing countries would provide several opportunities for growth in the near future.
  
North America was the highest revenue generating region in 2017 and is expected to head the global market during the analysis period. The large patient pool, favorable reimbursement policies, well-defined government and healthcare policies, widespread adoption of remote patient monitoring and healthcare services drive the market growth in the region. Asia-Pacific is expected to exhibit the fastest growth during the forecast period owing to improving medical facilities, increasing disposable income and rapidly increasing patient pool in emerging countries such as China, Japan, and India.

Get Discount On this Report: https://www.polarismarketresearch.com/industry-analysis/ultrasound-devices-market/request-for-discount-pricing

The types of ultrasound devices include diagnostic and interventional devices. In 2017, the diagnostic devices segment accounted for the highest market share owing to government initiatives to carry out routine check-ups and increasing adoption of fetal health monitoring. The improving medical facilitates and increasing demand due to rising number of patients, especially in developing countries, supports the market growth in this sector.

The key players profiled in this report include Toshiba Medical Systems Corporation, SonaCare Medical, Analogic Corporation, GE Healthcare, Koninklijke Philips N.V., Philips Healthcare, Siemens AG, FUJIFILM Holdings Corporation Hitachi Medical Corporation, Esaote S.p.A. Samsung Medison, Shimadzu Corporation and Mindray Medical International Limited among others. These companies have adopted new product launches to gain a competitive edge in the market.

Buy Now :  https://www.polarismarketresearch.com/checkouts/1191

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com



on No comments:
Labels: , , , ,

Surgical Microscope Market Analytical Overview, Growth Factors, Demand and Trends Forecast to 2026

New York City, 04 Feb 2020: According to a new study published by Polaris Market Research, the global surgical microscopes market is anticipated to reach over USD 1,740.4 million by 2026. In 2017, the ophthalmic microscopes segment dominated the global market, in terms of revenue. Among regions, North America accounted for the majority share in the global surgical microscopes market.
According to the World Health Organization (WHO), cancer is the leading cause of death around the globe. Thus, there is a great demand for surgical microscopes to improve diagnostic efficiency and decide prognosis of a disease. Moreover, increase in the number of surgeries, advancements in healthcare facilities, customized microscopy solutions, and technological advancements are the major factors driving the market growth. Moreover, growth in geriatric population, rise in adoption of minimally invasive ENT surgeries, and improved reimbursement policies for ENT surgeries further bolsters the growth of the market. Furthermore, surge in the number of outpatient facilities and increased per capita healthcare expenditure of various countries supplement the market growth.  
 In 2009, average health spending reached 9.5% of gross domestic product, up from 8.8% in 2008. The healthcare spending in most of the OECD countries has increased by margins greater than the gross domestic product. Moreover, the U.S. spent USD 1.9733 trillion for health care expenditures in 2005, which was 15.9% of the gross domestic product (GDP); of which, twenty-nine percent of the expenditures were allocated to surgical revenues. Thus, increase in population coupled with expansion of healthcare infrastructure and favorable scenarios for medical reimbursement programs have led to surge in the adoption of surgical microscopes. The adoption of surgical microscopes in ENT application has increased due to rise in prevalence of chronic sinusitis, growth in geriatric population, increase in adoption of minimally invasive surgeries, and implementation of favorable reimbursement policies for ENT surgeries. Technological advancements in surgical microscopes such as integrating intelligence, video, intraoperative-imaging, and navigation technologies enable surgeons to improve their decision-making at the point-of-care (POC) centers and provide best possible outcomes to patients.
 Surgical microscopes have been widely used in ophthalmology, as these microscopes help surgeons to perform intricate surgeries with precision and visualize the anatomy of small cavities. Increasing incidence of eyesight and vision disorders has fueled the use of ophthalmic microscopes across the globe.
 In addition, the dentistry segment is expected to witness significant growth in the near future, especially in the developing regions due to increase in the number of out-patient facilities and growing per capita healthcare expenditure. Growth in neurosurgery & spine surgery application segments is expected to be driven by surge in research and development activities related to tissue clearing and targeted cell labeling for brain functions.
  The key players profiled in the report are Carl Zeiss AG, Leica Microsystems, Takagi Corporation, Seiler Precision Microscopes, Topcon Corporation, Alltion (Wuzhou) Co. Ltd., Alcon Laboratories, Inc., Haag-Streit Surgical, Olympus Corporation, Accu-scope, Inc., Novartis AG, Danaher Corporation, Labomed Microscopes, and Prescott’s Inc. The prominent players operating in the industry have adopted various strategies such as business and capacity expansion, acquisitions, partnerships, mergers, and application & product development.
 about Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
 Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com


on No comments:
Labels: , , , ,

Pet Wearable Market Huge Demand & Future Scope Including Top Players


New York City, 04 Feb 2020: The worldwide pet wearable market is anticipated to reach USD 4,172 million by 2026 according to a new research published by Polaris Market Research. In 2017, the identification and tracking segment dominated the global market, in terms of revenue. In 2017, North America accounted for the majority share in the global pet wearable market.

The increasing adoption of pets, along with growing awareness regarding pet care and safety majorly drives the market growth. Consumers are increasingly becoming aware of safety concerns regarding pets, which support market growth. The increasing penetration of mobile devices, and increasing disposable income encourage consumers to invest in pet wearable. Other factors driving market growth include increasing need of monitoring pets, growing adoption of IOT, and technological advancements. New emerging markets, emerging consumer demographics, and sale through online channels would provide growth opportunities for pet wearable market in the coming years.Sale of products through online channels has gained significant popularity over the years.


The trend of online shopping is gaining traction in developing economies, thereby encouraging established market players to distribute their products globally. Emerging and new players are also using online platforms for promotion and sale of products. Online distribution channels offer a global platform to market players for expansion of customer base, while reducing operation cost.
  
North America is expected to dominate the global market during the forecast period. This is due to high living standards and high disposable income. Presence of global players in these countries taps market potential and boosts the market growth. Increasing use of mobile devices and increasing sale of GPS-enabled products further augments market growth. Growing concerns regarding pet safety, and technological advancements further boost the market growth.


The various types of pet wearable products include smart collar, smart camera, smart harness, and others. Smart cameras dominated the global market in 2017 owing to increase need to monitor pets. These cameras monitor the pet activities while also offering features such as audio and toys. Growing awareness regarding smart wearable technology coupled with increasing development of customized mobile applications and software platforms is projected to fuel the demand for smart cameras.

The well-known companies profiled in the report include DogTelligent, Garmin Ltd., GoPro, Dairymaster, Fitbark, IceRobotics, Loc8tor, PetPace LLC, Whistle Labs LLC, Otto Petcare, DeLaval, i4C Innovations. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.


About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com



on No comments:
Labels: , , ,

Monoclonal Antibodies mAbs Market Growth, Statistics, by Application, Production, Revenue & Forecast to 2026

New York City, 04 Feb 2020: According to a new study published by Polaris Market Research the worldwide monoclonal antibodies market is anticipated to reach over USD 148.9 billion by 2026. In 2017, by indication, the cancer segment dominated the global market in terms of revenue; wherein fully-human monoclonal antibodies held a major share of the market. In terms of geography, North America accounted for the majority share in the global monoclonal antibodies market.
The monoclonal antibodies (mAbs) market is mainly driven by an active pipeline, wherein many monoclonal antibodies are at the different stages of drug development. In addition, increased in research and development, favorable government policies and rising prevalence of cancer and other chronic diseases supplement the market growth. The other factors that augment that market growth include the increasing the demand for personalized medicine and rising awareness among medical professional and patients about the latest medical therapies. Moreover, emerging targets such as central nervous system disorders, price correction and new delivery strategies for monoclonal antibodies provide opportunities for market growth in the near future.
Monoclonal antibodies constitute a major share of the pharmaceutical market with several monoclonal antibodies still in the pipeline. With over 30 monoclonal antibodies approved for use by regulatory authorities, many monoclonal antibodies are in the pipeline at the pre-clinical stage and various stages of clinical trials. Furthermore, availability of advanced technology for monoclonal antibodies production has egged on many other market players to develop their own pipelines. Also, in the last few years the patents of many monoclonal antibodies have expired thereby encouraging other pharmaceutical companies to undertake production of monoclonal antibodies.
 There has been an increase in the research and development activities in the field of monoclonal antibodies. Several biomedical and technological advances in genetic engineering and next generation genome sequencing have fuelled the growth of the monoclonal antibody market. Also, multiple new targets have been identified during preclinical research, which has led to the development and production of newer monoclonal antibodies by using various cytotechnological methodologies. In addition to this, favorable government initiatives to enable cost-effective production of monoclonal antibodies would give impetus to the monoclonal antibodies market growth. Also, pre-defined guidelines by regulatory bodies would ensure the safe, effective and high quality manufacturing of monoclonal antibodies Recently, the European Commission approved the first biosimilar mAb Celltrion’s Truxima (biosimilar rituximab), thereby boding well for its potential approval in the U.S.
 Personalized medicine is being redefined by monoclonal antibodies that are the cutting-edge form of immunotherapy. The surge in the demand for personalized medicine plays a crucial role in boosting the monoclonal antibodies market by giving an impetus to the development of personalized drug targets as every patient responds differently to different treatment regimens. Moreover, other factors such as specificity, homogeneity and relatively fewer adverse events that entail usage of personalized medicine contribute to significant market growth.
 The widespread and rapidly increasing prevalence of cancer and other chronic diseases have resulted in the soaring demand of biological medicines, thereby augmenting the growth of monoclonal antibodies. Furthermore several other monoclonal antibodies used in treatment of deadly infections such as HIV/AIDS, Ebola and Zika viral disease are in various phases of clinical trials. Also, high spending power of patients in developed countries, increasing disposable incomes in developing countries and better healthcare facilities further facilitate market growth. Going forward, increasing awareness about the latest medical therapies among medical professional and patients, and increasing utilization of monoclonal antibodies in treatment regimens is anticipated to propel the market growth.
The leading companies operating in this industry include Pfizer, Inc., GlaxoSmithKline PLC, Novartis AG, Merck & Co., Inc., Eli Lily & Co., AstraZeneca, Amgen, Inc., Abbott Laboratories, Thermo Fisher Scientific, Inc., Bistro-Myers Squibb. Mylan N.V., Daiichi Sankyo Company, Ltd., Bayer AG, Hoffmann-La Roche Ltd., and Novo Nordisk A/S. The market players have adopted various strategies such as novel product development, new product release, and venture capital investments among others to establish a foothold in the market and increase their customer base.
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

on No comments:
Labels: , ,

Monday, 3 February 2020

Cell culture Market Size, Trends & Industry Analysis Report 2026


New York City, 03 Feb 2020: The global cell culture market is expected to reach more than USD 42.9 billion by 2026 with a CAGR of 11.8% during the forecast period as per a new study released by Polaris Market Research. The report “Cell Culture Market Share, Size, Trends & Industry Analysis Report By Consumables (Media, Sera, Reagents); By Product (Pipetting Instruments, Centrifuges, Biosafety Instruments, Culture Systems, Incubators, Cryostorage Equipment); By Application and By Regions: Segment Forecast, 2019 – 2026”. provides an extensive analysis of present market dynamics and predicted future trends.

 Cell culture is swiftly developing as an implement for evaluating and treating ailments such as Alzheimer’s and cancer diseases. Major Players are intending on broadening their cell reservoir and enhancing their efficiency by putting significant importance on recruitment of trained experts in order to gain a moderate threshold in the market. It is also estimated that the cell culture technique is also obtaining global acceptance in the food and beverages sector and this trend is anticipated to have a good grip in 2018. Cell culture is also gaining traction as one of the most important aspect in the development of high-quality plant actives.


The requirement for cell culture has improved to an extent where conventional manual handling and development of the culture is incapable fulfill the increasing demands. This has enabled the development of automated considerable scale cell culture outlines that are furnished for providing high output of cell societies of high purity levels and in larger quantities. The constant development of these systems and functions for cell culture has stabilized this market to anticipate a growth and advancement through to 2026. This improvement has moved the market noticeably and the cell culture market is predicted to gain a significant traction during the forecast period.
  
This growth can be attributed to the developing requirements for biopharmaceutical development, antibodies and protein generation; all of which depend intensely on cytological R&D where cell culture plays a notable part. Growing demand for biopharmaceutical is furthermore assumed to sustain regional market development over the forecast period.

The automated culture systems give remarkably improved limit managing, increased productiveness and reproducible purity levels. Sturdy federal initiatives associating to growing speculations by companies and governments in biopharmaceutical assembling and high undiscovered market openings are some imperative variables representing such quick development.


The United States and Canada represented the biggest market share in 2018, as there are a substantially high variety of R&D going in the area pertaining to cytological examination for proteomics, genomics, and also medication as well as vaccination advancement. Expanding requirement for biopharmaceuticals is likewise prepared for to sustain local market development throughout the forecast period.

The Asia Pacific region is anticipated to witness considerable development during 2019 to 2026 due to the existence of high demand for boosting manufacturing as well as advancement of vaccinations, medications, and also brand-new biologics. Helpful federal government efforts, increasing financial investments by market players and existence of federal governments in biopharma production as well as high untouched possibilities in the market are some of the vital elements which are helping this market to gain traction in this region.

Cell culture sera is estimated to represent over 45% of revenue generated in 2018 due to, high usage in cell culture composition and high prices of the product. It is also expected that the commercialization of sera is likewise anticipated to drive market in coming years.


Some of the major companies are associated with substantial R&D of 3D cell culture as well as complete commercialization of the technically sophisticated cell culture which use greater precision of duplication, better pureness and also quick development. Some of the major companies operating in this market consist of Thermo Fisher Scientific, Sartorius, General Electric, Merck, Sigma-Aldrich Co., LLC, Eppendorf, Promocell, Becton, Dickinson & Company (BD) and Lonza.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com





on No comments:
Labels: , , , ,
Subscribe to: Comments (Atom)